Abstract
A series of N-arylmethyl substituted (R)-5-methoxy-2-(propylamino)tetralins has been prepared and evaluated for affinity and efficacy at dopamine (DA) D2A receptors. The novel compounds appeared to be antagonists or inverse agonists. (R)-2-[(Benzyl)propylamino]-5-methoxytetralin (7) was characterized as a potent inverse agonists at DA D2A receptors in a [35S]GTPgammaS binding assay.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Dopamine Antagonists / chemical synthesis*
-
Dopamine Antagonists / chemistry
-
Dopamine Antagonists / pharmacology
-
Dopamine D2 Receptor Antagonists*
-
Guanosine 5'-O-(3-Thiotriphosphate) / metabolism
-
Humans
-
Radioligand Assay
-
Structure-Activity Relationship
-
Sulfur Radioisotopes
-
Tetrahydronaphthalenes / chemical synthesis*
-
Tetrahydronaphthalenes / pharmacology
Substances
-
2-((benzyl)propylamino)-5-methoxytetralin
-
Dopamine Antagonists
-
Dopamine D2 Receptor Antagonists
-
Sulfur Radioisotopes
-
Tetrahydronaphthalenes
-
Guanosine 5'-O-(3-Thiotriphosphate)